The largest database of trusted experimental protocols

Maxisorp immunotubes

Manufactured by Thermo Fisher Scientific
Sourced in United States, Denmark

MaxiSorp immunotubes are a type of microwell plate designed for immunoassays. They feature a high-binding surface to facilitate the immobilization of antibodies and antigens. The MaxiSorp surface is optimized for efficient protein binding, making these tubes suitable for a variety of immunological applications.

Automatically generated - may contain errors

6 protocols using maxisorp immunotubes

1

High-Throughput VNAR Library Screening

Check if the same lab product or an alternative is used in the 5 most similar protocols
All clones were isolated from a synthetic VNAR library containing 100 billion unique clones. Solid-phase, phage display library antigen selections were carried out as detailed previously [49 (link)] using MaxiSorp immunotubes (Nunc, 444474) coated with 1–0.1 μg/ml antigen in PBS pH 7.4. Predecorated biotinylated antigen bead selection protocols were adopted from our previous work [42 (link)]. Outputs from each selection round were screened for antigen-specific binders by monoclonal phage and periplasmic extract ELISAs against human or mouse ICOSL and unrelated protein controls at 1 μg/ml in PBS coating concentration. Phage binders were detected using HRP-conjugated anti-M13 antibody (GE Healthcare, 27942101), and periplasmic protein was detected using HRP-conjugated to an anti-c-Myc antibody (Roche, 118 141 50 001).
+ Open protocol
+ Expand
2

Phage Display for SARS-CoV-2 Spike RBD Sherpabodies

Check if the same lab product or an alternative is used in the 5 most similar protocols
Sherpabody phage display library (size ~1011 cfu) was obtained from Next Biomed Therapies Oy. To develop sherpabodies specific for SARS-CoV-2 spike receptor binding domain (RBD), phage affinity selection process was conducted using standard solid phase sorting strategy. Specific phage-displayed sherpabodies were selected for by panning against RBD-mouse IgG2a Fc-fusion protein35 (link). Three sequential rounds of off-target depletion and specific panning were performed using a control mFc and specific RBD-mFc, respectively. The immobilized control and target proteins (30 µg/ml in PBS; Maxisorp Immunotubes, Nunc) were sequentially incubated in the presence of infectious naïve sherpabody phage library in 2.5% milk-PBS-0.1%Tween20, for 2 h (RT) and o/n (4 °C), respectively. Non-specific phages were removed by extensive washing (PBS-0.05% PBS-Tween), and the remaining pool of phage were eluted and amplified in E. coli XL1-Blue host cells (Avantor; #AGLS200249) according to standard protocols. The amplified pool of phages was collected, and the process was reiterated over three rounds to enrich phage-displayed sherpabodies specific to the RBD-target protein.
+ Open protocol
+ Expand
3

Screening for HER2-specific Antibodies

Check if the same lab product or an alternative is used in the 5 most similar protocols
The phagemid DNA libraries were introduced into E. coli XL1-blue-MRF’ (Stratagene, USA) by electroporation (Sidhu et al., 2000 (link)), and the transformants were infected with Ex12 helper phages (Back et al., 2002 (link)).
To screen out HER2-specific antibodies from the libraries, MaxiSorp immunotubes (Nunc, 444202) were coated with human HER2-ECD (extracellular domain of ErbB2 or p185HER2, fused with Fc; R&D systems, USA). The libraries infected with Ex12 helper phage (IG therapy, Korea) were then used for panning according to the manufacturer’s instruction.
The stringency of panning was controlled in a washing step and the plates were washed up to 20 times with TBS-T. After washing, 1.0–1.5 M ammonium thiocyanate was treated for 10 min, followed by washing with TBS-T (Macdonald et al., 1998; Wang et al., 2000 (link)).
+ Open protocol
+ Expand
4

Enrichment of Human Serum Albumin-Binding VNARs

Check if the same lab product or an alternative is used in the 5 most similar protocols
Libraries were rescued and selected twice using Nunc Maxisorp immunotubes as previously described (26 (link)). For the first round of panning, tubes were washed five times with PBS containing 0.1% Tween 20 (PBS-T) and five times with PBS; for pan 2, the number of washes with and without Tween 20 was doubled. Following each round of panning, two 96-well plates of individual colonies were picked with a QPix2 XT (Genetix, San Jose, CA, USA) and grown for periplasmic protein extraction. Binding to HSA (and HEL control) was evaluated by ELISA using 50% of the crude periplasmic protein extract (27 (link)). VNARs were detected via their HA tag using a high-affinity mAb HRP conjugate (clone 3F10; Roche, Basel, Switzerland). All samples were processed with a Perkin Elmer MiniTrak robotic liquid handling system (Waltham, MA, USA).
+ Open protocol
+ Expand
5

VNAR Library Screening for DLL4 Binders

Check if the same lab product or an alternative is used in the 5 most similar protocols
VNAR phage display library screening VNAR E4 was isolated from a synthetic VNAR library containing 100 billion unique clones. Four rounds of solid phase, phage display antigen selections were carried out as described previously 18 using MaxiSorp immunotubes (Nunc) coated with 10-4 µg ml -1 rhDLL4 (recombinant human) in PBS pH 7.4. Outputs from each selection round were screened for specificity to human and murine DLL4 (1 µg ml -1 in PBS coating concentration) by monoclonal phage and periplasmic extract ELISAs. Phage binders were detected using HRP-conjugated anti-M13 antibody (Stratech Scientific), and periplasmic protein was detected using an HRP-conjugated anti-His antibody (Sigma-Aldrich).
+ Open protocol
+ Expand
6

Phage Display Screening of Bradyrhizobium Strains

Check if the same lab product or an alternative is used in the 5 most similar protocols
Selection was performed using Bradyrhizobium strains SUTN9-2 and DOA9 as targets. Two Maxisorp immuno tubes (Nunc, Denmark) were coated separately with 20 μg of boiled Bradyrhizobium strains, SUTN9-2 and DOA9, in sodium carbonate buffer at 4°C overnight. After that, the immuno tubes were washed three times with phosphate-buffered saline (PBS) and blocked with PBS containing 2% (wt/vol) skim milk (2% MPBS) for 2 h at room temperature. The tubes were washed three times with phosphate-buffered saline (PBS) before adding 10 μl (1011 PFU/μl) of phage library in 290 μl of 2% (wt/vol) MPBS and then incubated at room temperature for 2 h. Unbound phage was washed away with five times PBS supplemented with 0.1% (vol/vol) Tween 20 (PBST) and followed by 5 times PBS. Phage antibodies against each Bradyrhizobium strain was eluted with 1 μg/ml of trypsin buffer, followed by 0.1 M glycine-HCl, pH 2.0. To obtain individual phage clones, the eluted phage was infected with E. coli TG1 and incubated at 37°C for 30 min without shaking. Then, infected cells were subjected to 10-fold-serial dilution (101-104) and spread on 2x YT agar plates supplemented with 100 μg/ml ampicillin and 1% (wt/vol) glucose. The agar plates were incubated overnight at 37°C. Each single bacterial colony represents individual phage clone. One round of selection was carried out for both strains.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!